TrialBritish journal of haematology2014

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

Michinori Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.